Marek Sramko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marek Sramko has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
Josef Kautzner
Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
9 shared publications- Josef Kautzner
Department of Cardiology, Institute for Clinical and Experimental Medicine , Prague, Czechia
8 shared publications - Dan Wichterle
Department of Cardiology Institute for Clinical and Experimental Medicine Prague Czechia
6 shared publications - Vojtech Melenovsky
Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
6 shared publications - Petr Peichl
Department of Cardiology, Institute for Clinical and Experimental Medicine , Prague
5 shared publications J Kautzner
Institute for Clinical and Experimental Medicine, Department of Cardiology, Prague, Czechia
3 shared publications
Latest Publications
- 1 October 2026
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 19 (10)
Left Atrial Remodeling and Functional Maladaptations in Obesity: An Invasive Pressure-Volume Analysis
BACKGROUND: Obesity is a major risk factor for atrial fibrillation and heart failure. We aimed to characterize left atrial (LA) structural and functional changes across body mass index (BMI) strata in patients with atrial fibrillation referred for catheter ablation. METHODS: We studied 1040 consecutive patients (67% men; mean age, 62 years; 71% in sinus rhythm). Participants were stratified by BMI (2 ). Comprehensive echocardiographic assessment of LA structure and function was integrated with invasive LA pressure measurements obtained via transseptal access during the ablation procedure. Associations across BMI strata were evaluated using regression analyses. RESULTS: Patients with higher BMI had larger estimated total blood and plasma volumes along with higher LA volumes and pressures, greater cyclic wall stress, and a rightward shift of the estimated LA pressure-volume relationship. Conversely, estimated operant LA stiffness did not differ across BMI strata. BMI-related differences in LA volume were attenuated by body surface area indexing but preserved with height-based indexing. Conventional volumetric indices of LA phasic function were similar across BMI strata, whereas available LA strain indices (n=107) were lower with greater adiposity, consistent with worse LA phasic function. Compared with patients without heart failure, those with heart failure exhibited more pronounced structural, functional, and hemodynamic atrial remodeling, consistent with a more advanced atrial myopathy phenotype. CONCLUSIONS: In patients undergoing atrial fibrillation ablation, higher BMI is associated with a predominantly load-related pattern of LA remodeling, characterized by larger LA volume and pressures, greater cyclic wall stress, and a rightward shift of the estimated pressure-volume relationship. BMI-associated early atrial remodeling may precede overt atrial dysfunction, potentially contributing to the link between excess adiposity, atrial fibrillation, and heart failure with preserved ejection fraction.
- 1 October 2026
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 19 (10)
Left Atrial Remodeling and Functional Maladaptations in Obesity: An Invasive Pressure-Volume Analysis
BACKGROUND: Obesity is a major risk factor for atrial fibrillation and heart failure. We aimed to characterize left atrial (LA) structural and functional changes across body mass index (BMI) strata in patients with atrial fibrillation referred for catheter ablation. METHODS: We studied 1040 consecutive patients (67% men; mean age, 62 years; 71% in sinus rhythm). Participants were stratified by BMI (2 ). Comprehensive echocardiographic assessment of LA structure and function was integrated with invasive LA pressure measurements obtained via transseptal access during the ablation procedure. Associations across BMI strata were evaluated using regression analyses. RESULTS: Patients with higher BMI had larger estimated total blood and plasma volumes along with higher LA volumes and pressures, greater cyclic wall stress, and a rightward shift of the estimated LA pressure-volume relationship. Conversely, estimated operant LA stiffness did not differ across BMI strata. BMI-related differences in LA volume were attenuated by body surface area indexing but preserved with height-based indexing. Conventional volumetric indices of LA phasic function were similar across BMI strata, whereas available LA strain indices (n=107) were lower with greater adiposity, consistent with worse LA phasic function. Compared with patients without heart failure, those with heart failure exhibited more pronounced structural, functional, and hemodynamic atrial remodeling, consistent with a more advanced atrial myopathy phenotype. CONCLUSIONS: In patients undergoing atrial fibrillation ablation, higher BMI is associated with a predominantly load-related pattern of LA remodeling, characterized by larger LA volume and pressures, greater cyclic wall stress, and a rightward shift of the estimated pressure-volume relationship. BMI-associated early atrial remodeling may precede overt atrial dysfunction, potentially contributing to the link between excess adiposity, atrial fibrillation, and heart failure with preserved ejection fraction.
- Open Access
- 27 February 2026
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 15 (8) , 622-626
Landiolol for rate control in decompensated heart failure due to atrial fibrillation: the LARISA trial
Rate control of atrial fibrillation (AF) in acute heart failure (AHF) with reduced left ventricular ejection fraction (LVEF) is challenging. We evaluated the safety and efficacy of intensive rate control (IRC) using landiolol with adjunctive digoxin. Forty patients with AHF due to AF [heart rate (HR) > 130/min, LVEF 20% or P = 0.016). At 2 h, HR decreased by 40% of the IRC group vs. 23% of standard therapy group (P = 0.045), and the primary endpoint was reached in 80% vs. 20% of the patients, respectively (P = 0.04). IRC resulted in greater dyspnoea relief and lung decongestion without excess hypotension or adverse events. At 24 h, outcomes between the groups were similar. In AHF with reduced LVEF, protocolized landiolol-based intensive rate control provides faster and safe HR reduction with early symptomatic benefit compared with standard therapy. Pre-registered Clinical Trial Number: ClinicalTrials.org: NCT04694092.
- 27 February 2026
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 15 (8) , 622-626
Open AccessLandiolol for rate control in decompensated heart failure due to atrial fibrillation: the LARISA trial
Rate control of atrial fibrillation (AF) in acute heart failure (AHF) with reduced left ventricular ejection fraction (LVEF) is challenging. We evaluated the safety and efficacy of intensive rate control (IRC) using landiolol with adjunctive digoxin. Forty patients with AHF due to AF [heart rate (HR) > 130/min, LVEF 20% or P = 0.016). At 2 h, HR decreased by 40% of the IRC group vs. 23% of standard therapy group (P = 0.045), and the primary endpoint was reached in 80% vs. 20% of the patients, respectively (P = 0.04). IRC resulted in greater dyspnoea relief and lung decongestion without excess hypotension or adverse events. At 24 h, outcomes between the groups were similar. In AHF with reduced LVEF, protocolized landiolol-based intensive rate control provides faster and safe HR reduction with early symptomatic benefit compared with standard therapy. Pre-registered Clinical Trial Number: ClinicalTrials.org: NCT04694092.
- 7 January 2026
- Published by Elsevier in JACC: Heart Failure
- Vol. 14 (6) , 102886
Hemodynamic Effects of Oral Ketone Ester in Acutely Decompensated Heart Failure With Low Cardiac Output Syndrome
- 7 January 2026
- Published by Elsevier in JACC: Heart Failure
- Vol. 14 (6) , 102886
Hemodynamic Effects of Oral Ketone Ester in Acutely Decompensated Heart Failure With Low Cardiac Output Syndrome
- Open Access
- 16 June 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (7)
Excellent interobserver agreement and steep learning curve for target volume delineation for stereotactic arrhythmia radioablation using a commercial software
Aims: Stereotactic arrhythmia radioablation (STAR) has emerged as bail-out treatment for ventricular tachycardia (VT). Accurate, reproducible, and easy-to-use data transfer from electroanatomical mapping (EAM) systems to radiotherapy planning CT is desirable. We aim to evaluate interobserver variability, ease of use, and learning curve for EAM based target volume (CardTV-EPinv) creation and transfer using available software packages. Methods and results: In patients considered for STAR, CardTV-EPinv were created using ADAS and Slicer3D for workflow comparison. Four CardTV-EPinv (clinically targeted volume and three mock targets) were created by an experienced operator and a 2nd-year medical student, based on endocardial EAM tags indicating VT substrate location. CardTV-EPinv sizes, Hausdorff distances (HDs), and workflow duration were measured to assess interobserver variability and learning curve. Agreement between CardTV-EPinv was high using ADAS and Slicer3D workflows (HD 3.64 mm [2.7–4.5]). ADAS workflow was faster and more robust (ADAS 26 min [24–29] vs. Slicer3D 65 min [61–70], P < 0.001; system crashes: ADAS 0 vs. Slicer3D 7). In 20 patients (80% non-ischaemic cardiomyopathy, LVEF 35 ± 14%), 80 CardTV-EPinv were created using ADAS. CardTV-EPinv size was similar for both observers (11.8 mL [10.1–13.7] vs. 10.7 mL [9.6–11.8], P = 0.17), with high interobserver agreement (HD 1.68 mm [1.45–1.96]; 95th percentile HD < 4.8 mm [3.5–5.7]). Linear regression showed a steep learning curve for the student (P = 0.01). Conclusion: CardTV-EPinv creation showed excellent interobserver agreement and was faster and more robust using ADAS than 3D slicer. The steep learning curve appears clinically relevant given the limited use of STAR even in high-volume VT ablation centres.
- 16 June 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (7)
Open AccessExcellent interobserver agreement and steep learning curve for target volume delineation for stereotactic arrhythmia radioablation using a commercial software
Aims: Stereotactic arrhythmia radioablation (STAR) has emerged as bail-out treatment for ventricular tachycardia (VT). Accurate, reproducible, and easy-to-use data transfer from electroanatomical mapping (EAM) systems to radiotherapy planning CT is desirable. We aim to evaluate interobserver variability, ease of use, and learning curve for EAM based target volume (CardTV-EPinv) creation and transfer using available software packages. Methods and results: In patients considered for STAR, CardTV-EPinv were created using ADAS and Slicer3D for workflow comparison. Four CardTV-EPinv (clinically targeted volume and three mock targets) were created by an experienced operator and a 2nd-year medical student, based on endocardial EAM tags indicating VT substrate location. CardTV-EPinv sizes, Hausdorff distances (HDs), and workflow duration were measured to assess interobserver variability and learning curve. Agreement between CardTV-EPinv was high using ADAS and Slicer3D workflows (HD 3.64 mm [2.7–4.5]). ADAS workflow was faster and more robust (ADAS 26 min [24–29] vs. Slicer3D 65 min [61–70], P < 0.001; system crashes: ADAS 0 vs. Slicer3D 7). In 20 patients (80% non-ischaemic cardiomyopathy, LVEF 35 ± 14%), 80 CardTV-EPinv were created using ADAS. CardTV-EPinv size was similar for both observers (11.8 mL [10.1–13.7] vs. 10.7 mL [9.6–11.8], P = 0.17), with high interobserver agreement (HD 1.68 mm [1.45–1.96]; 95th percentile HD < 4.8 mm [3.5–5.7]). Linear regression showed a steep learning curve for the student (P = 0.01). Conclusion: CardTV-EPinv creation showed excellent interobserver agreement and was faster and more robust using ADAS than 3D slicer. The steep learning curve appears clinically relevant given the limited use of STAR even in high-volume VT ablation centres.
- 23 August 2023
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 9 (11) , 2329-2338
Acute Hemodynamic Effect of a Novel Dual-Vein, Multisite Biventricular Pacing Configuration
- 23 August 2023
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 9 (11) , 2329-2338
Acute Hemodynamic Effect of a Novel Dual-Vein, Multisite Biventricular Pacing Configuration
- Open Access
- 14 November 2022
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 1051995
Trajectories and determinants of left ventricular ejection fraction after the first myocardial infarction in the current era of primary coronary interventions
Background: Left ventricular ejection fraction (EF) is an independent predictor of adverse outcomes after myocardial infarction (MI). However, current data on trajectories and determinants of EF are scarce. The present study aimed to describe the epidemiology of EF after MI.Methods: Data from a single-center prospectively-designed registry of consecutive patients hospitalized at a large tertiary cardiology center were utilized.Results: Out of 1,593 patients in the registry, 1,065 were hospitalized for MI type I (65.4% STEMI) and had no previous history of heart failure or MI. At discharge, EF < 40% was present in 238 (22.3%), EF 40–50% in 326 (30.6%) and EF > 50% in 501 (47.0%). Patients with EF < 40% were often those who suffered subacute and anterior STEMI, had higher heart rate at admission and higher maximal troponin level, and had more often HF signs requiring intravenous diuretics. Among subjects with EF < 40%, the follow-up EF was available in 166 (80% of eligible). Systolic function recovered to EF > 50% in 39 (23.1%), slightly improved to EF 40–50% in 44 (26.0%) and remained below 40% in 86 (50.9%). Systolic function improvement to EF > 40% was predicted by lower severity of coronary atherosclerosis, lower leukocyte count, and the absence of atrial fibrillation.Conclusions: Despite recent improvements in in-hospital MI care, one in five patients has systolic dysfunction at hospital discharge. Out of these, EF improves in 51%, and full recovery is observed in 23%. The severity of coronary atherosclerosis, inflammatory response to MI, and atrial fibrillation may affect EF recovery.
- 14 November 2022
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 1051995
Open AccessTrajectories and determinants of left ventricular ejection fraction after the first myocardial infarction in the current era of primary coronary interventions
Background: Left ventricular ejection fraction (EF) is an independent predictor of adverse outcomes after myocardial infarction (MI). However, current data on trajectories and determinants of EF are scarce. The present study aimed to describe the epidemiology of EF after MI.Methods: Data from a single-center prospectively-designed registry of consecutive patients hospitalized at a large tertiary cardiology center were utilized.Results: Out of 1,593 patients in the registry, 1,065 were hospitalized for MI type I (65.4% STEMI) and had no previous history of heart failure or MI. At discharge, EF < 40% was present in 238 (22.3%), EF 40–50% in 326 (30.6%) and EF > 50% in 501 (47.0%). Patients with EF < 40% were often those who suffered subacute and anterior STEMI, had higher heart rate at admission and higher maximal troponin level, and had more often HF signs requiring intravenous diuretics. Among subjects with EF < 40%, the follow-up EF was available in 166 (80% of eligible). Systolic function recovered to EF > 50% in 39 (23.1%), slightly improved to EF 40–50% in 44 (26.0%) and remained below 40% in 86 (50.9%). Systolic function improvement to EF > 40% was predicted by lower severity of coronary atherosclerosis, lower leukocyte count, and the absence of atrial fibrillation.Conclusions: Despite recent improvements in in-hospital MI care, one in five patients has systolic dysfunction at hospital discharge. Out of these, EF improves in 51%, and full recovery is observed in 23%. The severity of coronary atherosclerosis, inflammatory response to MI, and atrial fibrillation may affect EF recovery.
- Open Access
- 15 September 2022
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (2) , 554-560
Assessment of electrical dyssynchrony in cardiac resynchronization therapy: 12-lead electrocardiogram vs. 96-lead body surface map
The standard deviation of activation time (SDAT) derived from body surface maps (BSMs) has been proposed as an optimal measure of electrical dyssynchrony in patients with cardiac resynchronization therapy (CRT). The goal of this study was two-fold: (i) to compare the values of SDAT in individual CRT patients with reconstructed myocardial metrics of depolarization heterogeneity using an inverse solution algorithm and (ii) to compare SDAT calculated from 96-lead BSM with a clinically easily applicable 12-lead electrocardiogram (ECG). Cardiac resynchronization therapy patients with sinus rhythm and left bundle branch block at baseline (n = 19, 58% males, age 60 ± 11 years, New York Heart Association Classes II and III, QRS 167 ± 16) were studied using a 96-lead BSM. The activation time (AT) was automatically detected for each ECG lead, and SDAT was calculated using either 96 leads or standard 12 leads. Standard deviation of activation time was assessed in sinus rhythm and during six different pacing modes, including atrial pacing, sequential left or right ventricular, and biventricular pacing. Changes in SDAT calculated both from BSM and from 12-lead ECG corresponded to changes in reconstructed myocardial ATs. A high degree of reliability was found between SDAT values obtained from 12-lead ECG and BSM for different pacing modes, and the intraclass correlation coefficient varied between 0.78 and 0.96 (P < 0.001). Standard deviation of activation time measurement from BSM correlated with reconstructed myocardial ATs, supporting its utility in the assessment of electrical dyssynchrony in CRT. Importantly, 12-lead ECG provided similar information as BSM. Further prospective studies are necessary to verify the clinical utility of SDAT from 12-lead ECG in larger patient cohorts, including those with ischaemic cardiomyopathy.
- 15 September 2022
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (2) , 554-560
Open AccessAssessment of electrical dyssynchrony in cardiac resynchronization therapy: 12-lead electrocardiogram vs. 96-lead body surface map
The standard deviation of activation time (SDAT) derived from body surface maps (BSMs) has been proposed as an optimal measure of electrical dyssynchrony in patients with cardiac resynchronization therapy (CRT). The goal of this study was two-fold: (i) to compare the values of SDAT in individual CRT patients with reconstructed myocardial metrics of depolarization heterogeneity using an inverse solution algorithm and (ii) to compare SDAT calculated from 96-lead BSM with a clinically easily applicable 12-lead electrocardiogram (ECG). Cardiac resynchronization therapy patients with sinus rhythm and left bundle branch block at baseline (n = 19, 58% males, age 60 ± 11 years, New York Heart Association Classes II and III, QRS 167 ± 16) were studied using a 96-lead BSM. The activation time (AT) was automatically detected for each ECG lead, and SDAT was calculated using either 96 leads or standard 12 leads. Standard deviation of activation time was assessed in sinus rhythm and during six different pacing modes, including atrial pacing, sequential left or right ventricular, and biventricular pacing. Changes in SDAT calculated both from BSM and from 12-lead ECG corresponded to changes in reconstructed myocardial ATs. A high degree of reliability was found between SDAT values obtained from 12-lead ECG and BSM for different pacing modes, and the intraclass correlation coefficient varied between 0.78 and 0.96 (P < 0.001). Standard deviation of activation time measurement from BSM correlated with reconstructed myocardial ATs, supporting its utility in the assessment of electrical dyssynchrony in CRT. Importantly, 12-lead ECG provided similar information as BSM. Further prospective studies are necessary to verify the clinical utility of SDAT from 12-lead ECG in larger patient cohorts, including those with ischaemic cardiomyopathy.
- Open Access
- 18 May 2022
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 24 (Supplement)
Measurement of electrical dyssynchrony in CRT patients: 12-lead ECG versus 96-lead body surface map
Funding Acknowledgements: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Grant agency AZV, Ministry of Health of the Czech Republic Background: Quantification of electrical dyssynchrony would allow optimization of lead placement and timing in patients with CRT. The standard deviation of activation times (SDAT) derived from body surface maps (BSM) was proposed as a measure of electrical dyssynchrony in CRT patients. However, SDAT derived from standard 12-lead ECG would be clinically preferred. Objective: To evaluate and compare the SDAT measured from BSM and 12-lead ECG for assessment of electrical resynchronization in patients with implanted CRT. Methods: CRT patients with sinus rhythm and LBBB at baseline (n=19, 58% males; age 60±11 years; NYHA class II-III; QRS 160±29) were studied using 96-lead BSM. For each ECG lead, the activation time was automatically detected and SDAT was calculated using either 96 leads or standard 12 leads. Electrical dyssynchrony was assessed during native sinus rhythm and 6 different pacing modes (see figure). Results: SDAT calculated from BSM and 12-lead ECG decreased during optimal BiV pacing as compared to sinus rhythm by 26% (p=0.006) and 30% (p=0.003), respectively. The two other BiV setups showed also a decrease in SDAT values. Importantly, a high degree of reliability was found between values of SDAT obtained from12-lead ECG and 96-lead BSM for different pacing modes, the intraclass correlation coefficient was 0.8 to 0.9 (95% CI 0.7 - 0.9, p<0.001). Conclusion: SDAT assessment is considered an important metric of electrical dyssynchrony in CRT. Our results suggest that 12-lead ECG provides similar results as BSM and thus, allows simplification of the measurement. Further prospective studies are necessary to verify the clinical utility of SDAT from 12-lead ECG.
- 18 May 2022
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 24 (Supplement)
Open AccessMeasurement of electrical dyssynchrony in CRT patients: 12-lead ECG versus 96-lead body surface map
Funding Acknowledgements: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Grant agency AZV, Ministry of Health of the Czech Republic Background: Quantification of electrical dyssynchrony would allow optimization of lead placement and timing in patients with CRT. The standard deviation of activation times (SDAT) derived from body surface maps (BSM) was proposed as a measure of electrical dyssynchrony in CRT patients. However, SDAT derived from standard 12-lead ECG would be clinically preferred. Objective: To evaluate and compare the SDAT measured from BSM and 12-lead ECG for assessment of electrical resynchronization in patients with implanted CRT. Methods: CRT patients with sinus rhythm and LBBB at baseline (n=19, 58% males; age 60±11 years; NYHA class II-III; QRS 160±29) were studied using 96-lead BSM. For each ECG lead, the activation time was automatically detected and SDAT was calculated using either 96 leads or standard 12 leads. Electrical dyssynchrony was assessed during native sinus rhythm and 6 different pacing modes (see figure). Results: SDAT calculated from BSM and 12-lead ECG decreased during optimal BiV pacing as compared to sinus rhythm by 26% (p=0.006) and 30% (p=0.003), respectively. The two other BiV setups showed also a decrease in SDAT values. Importantly, a high degree of reliability was found between values of SDAT obtained from12-lead ECG and 96-lead BSM for different pacing modes, the intraclass correlation coefficient was 0.8 to 0.9 (95% CI 0.7 - 0.9, p<0.001). Conclusion: SDAT assessment is considered an important metric of electrical dyssynchrony in CRT. Our results suggest that 12-lead ECG provides similar results as BSM and thus, allows simplification of the measurement. Further prospective studies are necessary to verify the clinical utility of SDAT from 12-lead ECG.
- Open Access
- 1 May 2022
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 29 (Supplement)
Interleukin-6 predicts recovery of systolic function after myocardial infarction
Funding Acknowledgements: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Ministry of Health of the Czech Republic Background: Interleukin (IL)-6 is an important mediator of the inflammatory response to acute myocardial infarction (MI). Increased IL-6 levels are associated with adverse outcomes after MI. However, there are only limited data on the association of IL-6 levels with recovery of systolic function after MI. Purpose: The aim of the present study was to evaluate the independent predictive value of IL-6 level for recovery of systolic function among patients hospitalized for their first MI. Methods: Consecutive patients without previous history of MI or cardiomyopathy with left ventricular ejection fraction (LVEF) ≤40% measured by transthoracic echocardiography upon hospital discharge and available follow-up LVEF evaluated between 3 months and one year since hospital discharge were selected from a prospective registry of MI patients (n=1323). Results: In total, data from 183 patients (mean age 64.2±11.2, 29% female, mean EF upon discharge 32.6±5.8) were analyzed. In the multivariate linear regression, IL-6 level measured within 24 hours from the hospital admission was positively associated with NT-proBNP, maximal hs-Troponin T a glycemia level and negatively with female gender, total cholesterol and admission systolic blood pressure. During follow-up, LVEF increased by 6.1±9.0% and LVEF recovered to value >50% in 43 (23.5%) patients. In the multivariate analysis, LVEF improvement was predicted by lower IL-6, lower maximal troponin level, female gender, lower heart rate at the time of hospital admission and Killip class I. In the ROC analysis (AUC 0.72, p<0.001), IL-6 ≤ 15.7ng/L had 51% sensitivity and 87% specificity to predict LVEF recovery. Conclusion: The inflammatory response to MI, as assessed by IL-6, is associated with MI size, glucose and lipid metabolism and is lower in women. IL-6 independently predicts change in LVEF among patients with moderate to severe LV dysfunction. This supports previous findings that IL-6 inhibition can increase myocardial salvage after MI and identifies possible patients that may benefit from targeted therapy.
- 1 May 2022
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 29 (Supplement)
Open AccessInterleukin-6 predicts recovery of systolic function after myocardial infarction
Funding Acknowledgements: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Ministry of Health of the Czech Republic Background: Interleukin (IL)-6 is an important mediator of the inflammatory response to acute myocardial infarction (MI). Increased IL-6 levels are associated with adverse outcomes after MI. However, there are only limited data on the association of IL-6 levels with recovery of systolic function after MI. Purpose: The aim of the present study was to evaluate the independent predictive value of IL-6 level for recovery of systolic function among patients hospitalized for their first MI. Methods: Consecutive patients without previous history of MI or cardiomyopathy with left ventricular ejection fraction (LVEF) ≤40% measured by transthoracic echocardiography upon hospital discharge and available follow-up LVEF evaluated between 3 months and one year since hospital discharge were selected from a prospective registry of MI patients (n=1323). Results: In total, data from 183 patients (mean age 64.2±11.2, 29% female, mean EF upon discharge 32.6±5.8) were analyzed. In the multivariate linear regression, IL-6 level measured within 24 hours from the hospital admission was positively associated with NT-proBNP, maximal hs-Troponin T a glycemia level and negatively with female gender, total cholesterol and admission systolic blood pressure. During follow-up, LVEF increased by 6.1±9.0% and LVEF recovered to value >50% in 43 (23.5%) patients. In the multivariate analysis, LVEF improvement was predicted by lower IL-6, lower maximal troponin level, female gender, lower heart rate at the time of hospital admission and Killip class I. In the ROC analysis (AUC 0.72, p<0.001), IL-6 ≤ 15.7ng/L had 51% sensitivity and 87% specificity to predict LVEF recovery. Conclusion: The inflammatory response to MI, as assessed by IL-6, is associated with MI size, glucose and lipid metabolism and is lower in women. IL-6 independently predicts change in LVEF among patients with moderate to severe LV dysfunction. This supports previous findings that IL-6 inhibition can increase myocardial salvage after MI and identifies possible patients that may benefit from targeted therapy.
- Open Access
- 1 May 2022
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 11 (Supplement)
Time trends in 30-day mortality in patients with pulmonary embolism
Funding Acknowledgements: Type of funding sources: None. Background: There is a lack of evidence about recent mortality rates in patients with acute pulmonary embolism (PE). Purpose: To compare 30-day mortality between the current and historical cohort of patients treated for acute PE. Methods: We provide a retrospective analysis of clinical and imaging features of 400 consecutive patients who were admitted to our hospital with the diagnosis of acute pulmonary embolism between February 2010 and April 2021. Patients with out-of-hospital cardiac arrest without return of spontaneous circulation (14 patients) were excluded from the study cohort. The 30-day mortality was compared between patients admitted before January 2016 (n =178) and after January 2016 (n = 222). We stratified patients into low-, intermediate-, and high-risk group according to the ‘2019 ESC Guidelines on Acute Pulmonary Embolism’. Results: The diagnosis of pulmonary embolism was based on results of computed tomography (86%), pulmonary ventilation/perfusion scan (7%), echocardiography (7%) and autopsy (1%). Most patients were stratified as intermediate-risk (313 patients [78 %]), followed by low-risk (46 [12%]) and high-risk pulmonary embolism (41 [10%]). The risk-stratification profile did not differ between the current and historical cohort (79% vs. 77% for intermediate-risk, 12% vs. 11% for low-risk, and 9% vs. 12% for high-risk patients, all p> 0.05). Seventeen patients (4%) died within 30 days of admission to the hospital: ten patients in the high-risk (24%), seven in the intermediate-risk (2%), and none (0%) in the low-risk group (p <0.0001). There was no significant difference in 30-day mortality between the current and historical cohort (9 [4%] vs. 8 [4%], p = 0.83). In a multivariate regression analysis, only the initial presence of cardiogenic shock was associated with higher 30-day mortality. Conclusion: In-hospital mortality of patients with intermediate- and low-risk pulmonary embolism is lower than reported in the past and has not changed over the last decade. High-risk pulmonary embolism is associated with 24% 30-day mortality.
- 1 May 2022
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 11 (Supplement)
Open AccessTime trends in 30-day mortality in patients with pulmonary embolism
Funding Acknowledgements: Type of funding sources: None. Background: There is a lack of evidence about recent mortality rates in patients with acute pulmonary embolism (PE). Purpose: To compare 30-day mortality between the current and historical cohort of patients treated for acute PE. Methods: We provide a retrospective analysis of clinical and imaging features of 400 consecutive patients who were admitted to our hospital with the diagnosis of acute pulmonary embolism between February 2010 and April 2021. Patients with out-of-hospital cardiac arrest without return of spontaneous circulation (14 patients) were excluded from the study cohort. The 30-day mortality was compared between patients admitted before January 2016 (n =178) and after January 2016 (n = 222). We stratified patients into low-, intermediate-, and high-risk group according to the ‘2019 ESC Guidelines on Acute Pulmonary Embolism’. Results: The diagnosis of pulmonary embolism was based on results of computed tomography (86%), pulmonary ventilation/perfusion scan (7%), echocardiography (7%) and autopsy (1%). Most patients were stratified as intermediate-risk (313 patients [78 %]), followed by low-risk (46 [12%]) and high-risk pulmonary embolism (41 [10%]). The risk-stratification profile did not differ between the current and historical cohort (79% vs. 77% for intermediate-risk, 12% vs. 11% for low-risk, and 9% vs. 12% for high-risk patients, all p> 0.05). Seventeen patients (4%) died within 30 days of admission to the hospital: ten patients in the high-risk (24%), seven in the intermediate-risk (2%), and none (0%) in the low-risk group (p <0.0001). There was no significant difference in 30-day mortality between the current and historical cohort (9 [4%] vs. 8 [4%], p = 0.83). In a multivariate regression analysis, only the initial presence of cardiogenic shock was associated with higher 30-day mortality. Conclusion: In-hospital mortality of patients with intermediate- and low-risk pulmonary embolism is lower than reported in the past and has not changed over the last decade. High-risk pulmonary embolism is associated with 24% 30-day mortality.